Evidence map›Paper›PMID 26311858›Full record

ArticleJournal of clinical microbiology2016

Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.

C Hal Jones, Naglaa Mohamed, Eduardo Rojas, Lubomira Andrew, Johanna Hoyos, Julio C Hawkins, Lisa K McNeil, Qin Jiang, Leonard W Mayer, Xin Wang and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Population genomic variation inMicrobial genomics · 2026
    Article
  3. Article
  4. Article
  5. Development of a sequence-basedMicrobial genomics · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. RNA Thermometers in Bacterial Pathogens.Microbiology spectrum · 2018
    Review
  16. Article
  17. Observational
  18. COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis IN ASYMPTOMATIC CARRIERS.Revista do Instituto de Medicina Tropical de Sao Paulo · 2016
    Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

C Hal JonesPfizer Vaccine Research and Development, Pearl River, New York, USA hal.jones@pfizer.com.
Naglaa MohamedPfizer Vaccine Research and Development, Pearl River, New York, USA.
Eduardo RojasPfizer Vaccine Research and Development, Pearl River, New York, USA.
Lubomira AndrewPfizer Vaccine Research and Development, Pearl River, New York, USA.
Johanna HoyosPfizer Vaccine Research and Development, Pearl River, New York, USA.
Julio C HawkinsPfizer Vaccine Research and Development, Pearl River, New York, USA.
Lisa K McNeilPfizer Vaccine Research and Development, Pearl River, New York, USA.
Qin JiangPfizer Vaccine Research and Development, Pearl River, New York, USA.
Leonard W MayerMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Xin WangMeningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rodica GilcaInstitut National de Santé Publique du Québec, Quebec City, Canada Laval University, Quebec City, Canada CHU de Québec, Quebec City, Canada.
Philippe De WalsInstitut National de Santé Publique du Québec, Quebec City, Canada Laval University, Quebec City, Canada CHU de Québec, Quebec City, Canada.
Louise PedneaultPfizer Vaccine Research and Development, Pearl River, New York, USA.
Joseph EidenPfizer Vaccine Research and Development, Pearl River, New York, USA.
Kathrin U JansenPfizer Vaccine Research and Development, Pearl River, New York, USA.
Annaliesa S AndersonPfizer Vaccine Research and Development, Pearl River, New York, USA.
Pfizer (United States) · USCenters for Disease Control and Prevention · USCentre hospitalier universitaire de Québec · CAInstitut National de Santé Publique du Québec · CANational Center for Immunization and Respiratory Diseases · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisseria meningitidis serogroup B (MnB) is a leading cause of bacterial meningitis; however, MnB is most commonly associated with asymptomatic carriage in the nasopharyngeal cavity, as opposed to the disease state. Two vaccines are now licensed for the prevention of MnB disease; a possible additional benefit of these vaccines could be to protect against disease indirectly by disrupting nasopharyngeal carriage (e.g., herd protection). To investigate this possibility, accurate diagnostic approaches to characterize MnB carriage isolates are required. In contrast to invasive meningococcal disease (IMD) isolates, which can be readily serogrouped, carriage isolates often lack capsule expression, making standard phenotypic assays unsuitable for strain characterization. Several antibody-based methods were evaluated for their abilities to serogroup isolates and were compared with two genotyping methods (real-time PCR [rt-PCR] and whole-genome sequencing [WGS]) to identify which approach would most accurately ascertain the polysaccharide groups associated with carriage isolates. WGS and rt-PCR were in agreement for 99% of IMD isolates, including those with coding sequences for MnB, MnC, MnW, and MnY, and the phenotypic methods correctly identified serogroups for 69 to 98% of IMD isolates. In contrast, only 47% of carriage isolates were groupable by genotypic methods, due to mutations within the capsule operon; of the isolates identified by genotypic methods, ≤43% were serogroupable with any of the phenotypic methods tested. These observations highlight the difficulties in the serogrouping and capsular genogrouping of meningococcal carriage isolates. Based on our findings, WGS is the most suitable approach for the characterization of meningococcal carriage isolates.

Indexed as

AdolescentAdultBacterial CapsulesCarrier StateEpidemiologic StudiesFemaleGenotyping TechniquesHumansMaleNeisseriaceae InfectionsNeisseria meningitidisSerotypingYoung Adult

Identifiers

PMID26311858
PMCPMC4702718
OpenAlexW1702452676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.